Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

What symbol and exchange does Palisade Bio shares trade?

Palisade Bio trades on the NASDAQ stock market under the symbol PALI.

What is Palisade Bio stock price doing today?

As of October 23, 2026, PALI stock price declined to $1.33 with 1,124,437 million shares trading.

What is Palisade Bio's Beta?

PALI has a beta of 0.75, meaning it tends to be less sensitive to market movements. PALI has a correlation of 0.01 to the broad based SPY ETF.

How much is Palisade Bio worth?

PALI has a market cap of $231.78 million. This is considered a Small Cap stock.

What is the highest and lowest price Palisade Bio traded in the last 3 year period?

In the last 3 years, PALI traded as high as $22.35 and as low as $.53.

What are the top ETFs holding Palisade Bio?

The top ETF exchange traded funds that PALI belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.

Is Palisade Bio (PALI) a good investment?

PALI has underperformed the market in the last year with a price return of -18.4% while the SPY ETF gained +14.9%. PALI has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -30.0% and -8.3%, respectively, while the SPY returned +1.9% and -1.8%, respectively.

What are the support and resistance levels for Palisade Bio (PALI)?

PALI support price is $1.28 and resistance is $1.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PALI shares will trade within this expected range on the day.